Literature DB >> 25467645

Gastric cancer in three relatives of a patient with a biallelic IL12RB1 mutation.

Ingrid P Vogelaar1, Rachel S van der Post, Esther van de Vosse, J Han J M van Krieken, Nicoline Hoogerbrugge, Marjolijn J L Ligtenberg, Encarna Gómez García.   

Abstract

IL-12Rβ1 deficiency, also known as immunodeficiency 30 (IMD30, OMIM 614891), is a rare immunodeficiency syndrome caused by biallelic mutations in IL12RB1. Three second-degree relatives of a patient with this syndrome, all women, developed intestinal-type gastric cancer (GC). In the Netherlands the incidence of non-cardia GC in women is only 7 per 100,000 person years. Both relatives that were available for testing proved to be heterozygous for the familial IL12RB1 mutation, suggesting there might be a causal relation. Testing 29 index patients from families with early onset and/or a familial history of GC for germline mutations in both IL12RB1 and IL12RB2, that encodes the binding partner of IL-12Rβ1, did not reveal other germline mutations in these genes. Therefore heterozygous inactivating mutations in IL12RB1 and IL12RB2 are unlikely to be frequently involved in GC predisposition. Additional research in families with IL12RB1 mutations is required to determine whether carriers of IL12RB1 mutations have an increased (gastric) cancer risk.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25467645     DOI: 10.1007/s10689-014-9764-x

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  29 in total

Review 1.  Interleukin-12 in anti-tumor immunity and immunotherapy.

Authors:  Mario P Colombo; Giorgio Trinchieri
Journal:  Cytokine Growth Factor Rev       Date:  2002-04       Impact factor: 7.638

2.  Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy.

Authors:  Irma Airoldi; Emma Di Carlo; Claudia Cocco; Carlo Sorrentino; Franco Fais; Michele Cilli; Tommaso D'Antuono; Mario Paolo Colombo; Mario Paulo Colombo; Vito Pistoia
Journal:  Blood       Date:  2005-08-04       Impact factor: 22.113

3.  Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral.

Authors:  S V Tavtigian; A M Deffenbaugh; L Yin; T Judkins; T Scholl; P B Samollow; D de Silva; A Zharkikh; A Thomas
Journal:  J Med Genet       Date:  2005-07-13       Impact factor: 6.318

Review 4.  Genetics, pathology, and clinics of familial gastric cancer.

Authors:  Carla Oliveira; Raquel Seruca; Fátima Carneiro
Journal:  Int J Surg Pathol       Date:  2006-01       Impact factor: 1.271

Review 5.  Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.

Authors:  G Trinchieri
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

6.  Oesophageal squamous cell carcinoma in a young adult with IL-12R beta 1 deficiency.

Authors:  María Cárdenes; Alfonso Angel-Moreno; Claire Fieschi; Ithaisa Sologuren; Elena Colino; Antonio Molinés; M Isabel García-Laorden; M Isolina Campos-Herrero; Miguel Andújar-Sánchez; Jean-Laurent Casanova; Carlos Rodríguez-Gallego
Journal:  J Med Genet       Date:  2010-09       Impact factor: 6.318

7.  Family history and the risk of stomach and colorectal cancer.

Authors:  C La Vecchia; E Negri; S Franceschi; A Gentile
Journal:  Cancer       Date:  1992-07-01       Impact factor: 6.860

Review 8.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

9.  Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.

Authors:  Pardeep Kaurah; Andrée MacMillan; Niki Boyd; Janine Senz; Alessandro De Luca; Nicki Chun; Gianpaolo Suriano; Sonya Zaor; Lori Van Manen; Cathy Gilpin; Sarah Nikkel; Mary Connolly-Wilson; Scott Weissman; Wendy S Rubinstein; Courtney Sebold; Robert Greenstein; Jennifer Stroop; Dwight Yim; Benoit Panzini; Wendy McKinnon; Marc Greenblatt; Debrah Wirtzfeld; Daniel Fontaine; Daniel Coit; Sam Yoon; Daniel Chung; Gregory Lauwers; Antonio Pizzuti; Carlos Vaccaro; Maria Ana Redal; Carla Oliveira; Marc Tischkowitz; Sylviane Olschwang; Steven Gallinger; Henry Lynch; Jane Green; James Ford; Paul Pharoah; Bridget Fernandez; David Huntsman
Journal:  JAMA       Date:  2007-06-03       Impact factor: 56.272

10.  Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.

Authors:  Rebecca C Fitzgerald; Richard Hardwick; David Huntsman; Fatima Carneiro; Parry Guilford; Vanessa Blair; Daniel C Chung; Jeff Norton; Krishnadath Ragunath; J Han Van Krieken; Sarah Dwerryhouse; Carlos Caldas
Journal:  J Med Genet       Date:  2010-07       Impact factor: 6.318

View more
  4 in total

Review 1.  Hereditary gastric cancer: what's new? Update 2013-2018.

Authors:  Rachel S van der Post; Carla Oliveira; Parry Guilford; Fátima Carneiro
Journal:  Fam Cancer       Date:  2019-07       Impact factor: 2.375

2.  rs401502 and rs11575934 Polymorphisms of the IL-12 Receptor Beta 1 Gene are Protective Against Colorectal Carcinogenesis.

Authors:  Refka Jelassi; Sabrine Dhouioui; Hamza Ben Salah; Nasreddine Saidi; Nabiha Mzoughi; Radhia Ammi; Aida Bouratbine; Karim Aoun; Ines Zidi; Hanen Chelbi
Journal:  Front Genet       Date:  2022-05-13       Impact factor: 4.772

Review 3.  Hereditary diffuse gastric cancer: What the clinician should know.

Authors:  Ryan Ying Cong Tan; Joanne Ngeow
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

4.  Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer.

Authors:  Daniel Chubb; Peter Broderick; Sara E Dobbins; Matthew Frampton; Ben Kinnersley; Steven Penegar; Amy Price; Yussanne P Ma; Amy L Sherborne; Claire Palles; Maria N Timofeeva; D Timothy Bishop; Malcolm G Dunlop; Ian Tomlinson; Richard S Houlston
Journal:  Nat Commun       Date:  2016-06-22       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.